Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
24,288,268
-
Share change
-
-413,242
-
Total reported value
-
$604,759,469
-
Put/Call ratio
-
248%
-
Price per share
-
$24.90
-
Number of holders
-
109
-
Value change
-
-$12,559,822
-
Number of buys
-
53
-
Number of sells
-
46
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q3 2015
As of 30 Sep 2015,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,288,268 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, OAK RIDGE INVESTMENTS LLC, Polaris Venture Management Co IV LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, ADAGE CAPITAL PARTNERS GP LLC, QVT Financial LP, JPMORGAN CHASE & CO, and Sectoral Asset Management Inc.
This page lists
109
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.